Cite

HARVARD Citation

    Gragnano, F. et al. (2022). CYP2C19 Genotyping to Risk Stratify Patients After Coronary Stent Implantation: Time for a Personalized Approach?. Journal of cardiovascular pharmacology. 79 (2), pp. 159-160. [Online]. 
  
Back to record